UAE Adopts Abridged Reviews For Faster Drug Approvals
Executive Summary
The United Arab Emirates has published a new decree setting out procedures for accelerated reviews of innovative and orphan medicines, creating a new standard for the rest of the gulf region.
You may also be interested in...
How Middle Eastern Markets Are Transforming Drug Reviews And Driving Competitiveness
The UAE, Jordan, Egypt and Saudi Arabia have all recently announced or implemented new verification/abridged regulatory pathways to improve access to medicines and free up resources.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.